참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2,5-Dichloronitrobenzene | HCID 6977 | — |
| 반응물 | Potassium Carbonate | HCID 11430 | — |
| 반응물 | Oxalic acid dihydrate | HCID 61373 | — |
| 반응물 | Citadiol, (S)- | HCID 7472057 | — |
| 용매 | Acetone | HCID 180 | — |
| 용매 | Dimethyl Sulfoxide | HCID 679 | — |
| 용매 | Water | HCID 962 | — |
| 생성물 | Escitalopram Oxalate | HCID 146571 | — |
반응 단계
To a solution of 6.0 gm of (S)-(−)-4-[4-(dimethylamino)-1-(4-fluorophenyl)-1-hydroxy-1-butyl]-3-(hydroxymethyl)benzonitrile in 30 ml of DMSO at room temperature was added 7.3 gm of anhydrous K2CO3 and 4.04 gm of 2,5-dichloronitrobenzene was added to the above reaction mixture at room temperature and stirred at 100° C. for 15.0 hours. To the above reaction mixture, 120 ml of water was added, and extracted with toluene. The toluene layer was washed with water and 5% sodium hydroxide solution and after acid base treatment yielded an oily product. The oil was dissolved in 16 ml of acetone at 30° C. and 1.9 gm of oxalic acid dihydrate in 8 ml of acetone was added to it, stirred, cooled, filtered and dried at 60° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07989645B2 |
|---|
| 출처 데이터셋 | uspto-grants-2011_08 |
|---|
| ORD ID | ord-7a213609d29543c4811ac4e2a999e69c |
|---|
| 출처 메모 | uspto-grants-2011_08 |
|---|